Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
34,85 HKD | -2,65 % | -5,30 % | -18,48 % |
Resumen de negocios
Número de empleados: 4 872
Ventas por actividad
HKD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Antibody and Protein Medicine, Pharmaceutical Products and Consultation and Research and Development
100,0
%
| 5 299 | 100,0 % | 6 858 | 100,0 % | +29,43 % |
Ventas por región
HKD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
China
92,7
%
| 4 806 | 90,7 % | 6 357 | 92,7 % | +32,29 % |
United States
7,1
%
| 478 | 9,0 % | 489 | 7,1 % | +2,32 % |
Others
0,2
%
| 15 | 0,3 % | 11 | 0,2 % | -24,88 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
De Chao Yu
CEO | Chief Executive Officer | 61 | 28/04/11 |
Fei You
DFI | Director of Finance/CFO | 45 | 05/02 |
Yong-Jun Liu
PSD | President | - | 15/10/20 |
Ghang Shou Gao
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/20 |
Qin Wei Zhou
COO | Chief Operating Officer | 61 | 16/06/16 |
Hao Xi Ede
BRD | Director/Board Member | 65 | 05/06/17 |
Vivian Zhang
HRO | Human Resources Officer | - | 01/03/12 |
Blake Salisbury
PRN | Corporate Officer/Principal | - | 01/03/16 |
Yan Ju Wang
SEC | Corporate Secretary | 36 | 01/10/15 |
Lok Yee Chan
SEC | Corporate Secretary | 35 | 04/06/18 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Gary Zieziula
BRD | Director/Board Member | 69 | 31/05/22 |
Charles Cooney
BRD | Director/Board Member | 80 | 18/10/15 |
De Chao Yu
CEO | Chief Executive Officer | 61 | 28/04/11 |
I Yin Hsu
BRD | Director/Board Member | 50 | 18/10/18 |
Hao Xi Ede
BRD | Director/Board Member | 65 | 05/06/17 |
Kai Xian Chen
BRD | Director/Board Member | 78 | 18/10/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 1 628 022 690 | 1 512 920 997 ( 92,93 %) | 0 | 92,93 % |
Información de la empresa
Innovent Biologics, Inc.
168 Dongping Street Suzhou Industrial Park
215123, Suzhou
+86 512 6956 6088
http://www.innoventbio.comVentas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-18,48 % | 7455,12 M | |
-0,12 % | 92,26 mil M | |
-3,16 % | 38,11 mil M | |
-12,42 % | 32,9 mil M | |
+65,46 % | 26,51 mil M | |
-13,88 % | 15,75 mil M | |
-7,33 % | 13,36 mil M | |
-10,50 % | 11,65 mil M | |
-49,84 % | 10,12 mil M | |
+156,85 % | 9778,67 M |
- Bolsa de valores
- Acciones
- Acción 1801
- Empresa Innovent Biologics, Inc.